Simon Property Group and 4 Stocks with New Analyst Ratings and Price Targets
ICU Medical, Inc. (NASDAQ:ICUI): Current Price: $62.17
ICU reported higher Q4 EPS than predicted, but it provided lower FY13 EPS guidance than previously predicted, influencing Roth Capital to believe that the guidance was affected by Hospira’s (NYSE:HSP) inventory reduction program. The firm is convinced that ICU’s guidance could be conservative.
Denbury Resources Inc. (NYSE:DNR): Current Price: $18.93
The company’s price target was increased by Baird after its update on its proven reserves due to the company’s solid tertiary execution as reaffirming its thesis of Denbury continuing to be a top idea for long-term oil exposure. The firm gives the stock an Outperform rating.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Carbonite Inc (NASDAQ:CARB): Current Price: $10.45
According to Canaccord, Carbonite’s quarter was solid and shares are inexpensive. Carbonite has a Buy rating.
Heartware International Inc. (NASDAQ:HTWR): Current Price: $90.84
Canaccord recommends increasing exposure to HeartWare as it predicts that HeartWare will have a very strong 2013 and notes that checks in the U.S. indicate that there is an upside to current estimates. The firm gives the stock a Buy rating and increased its price target to $144 from $107.
Simon Property Group Inc. (NYSE:SPG): Current Price: $162.89
Simon Property reported Q4 results that are seen as strong by Wells Fargo, as the firm notes that Simon’s 2012 FFO was 73c higher than its original guidance. The firm believes that Simon is one of the best real estate REITs, and it keeps its Outperform rating on the stock.